Clinical Trials · NCT01964170
A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 234
- Start date
- Aug 2013
- Locations
- 8 sites, Japan
- Primary endpoint
- Cumulative castration rate of treatment in terms of serum testosterone level